AbbVie Inc.
ABBV
$210.60
$1.100.53%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 938.00M | 1.29B | -22.00M | 1.56B | 1.37B |
| Total Depreciation and Amortization | 2.05B | 2.04B | 2.10B | 2.08B | 2.13B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.73B | 890.00M | 5.37B | 1.06B | 2.15B |
| Change in Net Operating Assets | -562.00M | -2.58B | -397.00M | 750.00M | -3.38B |
| Cash from Operations | 5.15B | 1.64B | 7.05B | 5.45B | 2.27B |
| Capital Expenditure | -269.00M | -235.00M | -291.00M | -249.00M | -241.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -940.00M | -538.00M | -1.79B | -8.49B | -843.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.00M | 38.00M | 209.00M | 486.00M | -18.00M |
| Cash from Investing | -1.18B | -735.00M | -1.87B | -8.26B | -1.10B |
| Total Debt Issued | 3.96B | 5.59B | 2.00B | 0.00 | 0.00 |
| Total Debt Repaid | -3.75B | -3.03B | -5.76B | -403.00M | -3.35B |
| Issuance of Common Stock | 5.00M | 56.00M | 10.00M | 67.00M | 10.00M |
| Repurchase of Common Stock | -12.00M | -961.00M | -358.00M | -17.00M | -9.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.91B | -2.93B | -2.75B | -2.75B | -2.75B |
| Other Financing Activities | -2.00M | 11.00M | 1.00M | 32.00M | 0.00 |
| Cash from Financing | -2.71B | -1.26B | -6.86B | -3.07B | -6.10B |
| Foreign Exchange rate Adjustments | 30.00M | 9.00M | -46.00M | 8.00M | -9.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.29B | -349.00M | -1.73B | -5.87B | -4.94B |